Pharmaceutical formulation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/38 (2006.01) A61K 9/20 (2006.01) A61K 31/397 (2006.01) A61K 38/05 (2006.01) A61P 9/00 (2006.01)

Patent

CA 2458473

The present invention provides, for example, a pharmaceutical formulation for oral administration comprising H 376/95, sodium dodecyl sulphate (SDS) and a polymer selected from the group comprising hydroxypropyl methylcellulose (HPMC), hydroxyethyl cellulose (HEC) and polyoxyethylene oxide (PEO), a process for the preparation of such a formulation and the medical use of the formulation in the treatment of thromboembolism.

L'invention concerne, par exemple, une formulation pharmaceutique pour administration orale contenant H 376/95, du dodécyl sulfate de sodium (SDS) et un polymère choisi dans le groupe contenant de l'hydroxypropylméthylcellulose (HPMC), de l'hydroxyéthylcellulose (HEC) et de l'oxyde de polyoxyéthylène (PEO). L'invention en question porte aussi sur un procédé de préparation de cette formulation, ainsi que sur l'utilisation médicale de ladite formulation dans le traitement du thromboembolisme.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1971016

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.